Gout
Crystal arthritis driven by high uric acid
What it is
Gout is a form of inflammatory arthritis caused by uric-acid crystals depositing in joints, producing sudden, severe attacks of pain and swelling (classically the big toe). It reflects sustained high uric acid and is closely tied to metabolic health.
Why it matters
Beyond the pain of attacks, gout is a marker of metabolic and kidney health — it travels with metabolic syndrome, hypertension, and chronic kidney disease. It is also very treatable: lowering uric acid to target prevents attacks and joint damage.
What BioSignal knows about treating this
What works for Gout
BioSignal’s clinical summary, most important first.
- Acute attacks: NSAIDs, colchicine, or steroids (clinician-directed)
- Urate-lowering therapy to target (e.g., allopurinol) for recurrent gout
- Reducing alcohol and sugary drinks
- Weight loss and metabolic-health improvement
- Reviewing medications that raise uric acid
New to this? Read these first
How this usually unfolds
- Recognize risk factors
- Get diagnosed
- Track key biomarkers
- Lifestyle first
- Evidence-based treatment
- Long-term monitoring
Who is at risk
- High uric acid (hyperuricemia)
- Alcohol (especially beer) and high-fructose intake
- Obesity and metabolic syndrome
- Chronic kidney disease
- Certain diuretics
- Diets high in purines (red/organ meats, some seafood)
How it's diagnosed
Diagnosed clinically and, ideally, by finding uric-acid crystals in joint fluid; serum uric acid supports the picture but can be normal during an acute attack. Imaging (ultrasound, dual-energy CT) can help.
Key biomarkers
Lifestyle
Explore this condition across BioSignal
Related Foundations
Related body systems
Related conditions
Frequently asked questions
Is gout just about diet?
Diet contributes (alcohol, sugary drinks, purine-rich foods), but genetics and kidney handling of uric acid matter as much or more. For recurrent gout, urate-lowering medication to target is the mainstay — diet alone often isn't enough.
Why does my uric acid matter for my kidneys and heart?
Gout and high uric acid cluster with metabolic syndrome, hypertension, and chronic kidney disease. Treating gout is also a prompt to address that broader cardiometabolic risk.
Evidence summary
Urate-lowering to target prevents gout attacks and tophi (well established); gout's association with cardiometabolic and kidney disease is well documented, while the cardiovascular benefit of lowering uric acid in asymptomatic people is not established.
References & sources
- ACR Guideline for the Management of Gout
- EULAR gout recommendations
Educational information — not medical advice
Is this condition page clear, accurate, and useful? Your feedback shapes what we review next.
Give feedback